Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum
These effects depend on the type, route of administration, dose, and duration of action of each specific GLP-1 receptor agonist, as well as individual characteristics such as baseline body weight and degree of glucose tolerance
Weight loss outcomes depend on dose, diet, exercise, and adherence to the protocol
Here are the major factors that determine your personal timeline
This highlights the importance of individualized dosing plans
In lean rats without T2DM, plasma levels of gluconeogenic amino acids were increased in a weight loss-independent manner after bariatric surgery, suggesting that substrate availability is not the limiting factor for reduced gluconeogenesis 29